Niquitin Clear (Nicotine)

Nicotine, the active ingredient in Niquitin Clear, is a nicotinic receptor agonist presented as a transdermal patch for transdermal use. It provides controlled nicotine delivery to reduce withdrawal symptoms and cravings, supporting adults who are trying to quit smoking.

GNH USA supplies Niquitin Clear as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, adhering to EU manufacturing standards and providing regulatory documentation to facilitate import and distribution across multiple regions.

Nicotine delivered via Niquitin Clear is used in nicotine‑replacement therapy to assist smoking cessation. - Smoking cessation: helps adults reduce cravings and withdraw from tobacco. - Aid to quit tobacco use: provides controlled nicotine to support quitting attempts. - Tobacco dependence: reduces withdrawal symptoms during cessation attempts.

Niquitin Clear may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Skin irritation at the patch site. - Sleep disturbance or insomnia. - Nausea. - Headache.

Serious or Rare Side Effects: - Allergic reaction such as rash or hives. - Severe skin reaction (contact dermatitis). - Cardiovascular symptoms like palpitations or increased blood pressure.

When using Niquitin Clear, certain precautions should be observed to ensure safety and effectiveness. - Assess suitability: confirm patient is an adult smoker seeking cessation. - Avoid use in patients with recent myocardial infarction. - Do not apply to broken or irritated skin. - Rotate application sites to minimize skin irritation. - Monitor for signs of nicotine overdose. - Store at room temperature: keep in original pouch, protect from moisture and direct sunlight.

Nicotine delivered by Niquitin Clear can interact with several medicines, affecting their activity or safety.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): increased risk of hypertensive crisis. - Certain antipsychotics (e.g., clozapine): altered plasma levels. - Beta‑blockers: reduced efficacy due to nicotine‑induced tachycardia.

Moderate Interactions (Monitor Closely): - Caffeine: increased stimulant effects. - Alcohol: enhanced intoxication. - Certain antidepressants (SSRIs): possible increased side effects.